Bridgeway Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
ACH
Bridgeway Capital Management's VCYT Position: Q2 2025 in Review
Bridgeway Capital Management sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 128,100 shares — an estimated $3.8M sold.
Bridgeway Capital Management first reported a position in VCYT in Q4 2014 and held it in 22 quarters. The position peaked at $6.79M in Q3 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.
- Bridgeway Capital Management reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
- Bridgeway Capital Management sold 128,100 Veracyte shares in Q2 2025, an estimated $3.8M.
- Bridgeway Capital Management first reported a position in Veracyte in Q4 2014 and held it in 22 quarters.
- Bridgeway Capital Management's Veracyte position peaked at $6.79M in Q3 2024.
- 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.
Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.